MYLAN-BUDESONIDE AQ
MYLAN-BUDESONIDE AQ
Approved
DIN Number
02241003
Drug Class
Human
Market Date
Nov 23, 1999
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02241003
AIG Number0116807010
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R01AD05 BUDESONIDE
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationNasal
AHFS Classification52:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
BUDESONIDEActive
Strength: 64 MCG / ACT
Monograph: BUDESONIDE